QYR:Global Medical Linear Accelerators Market Overview
LINAC (linear accelerator) is a must-have for any radiation oncology care provider. Approximately 60 percent of all cancer cases in the U.S. involve some form of radiation therapy, and recent technological improvements by linear accelerator manufacturers allow for unprecedented accuracy and safety in treating tumors, and limiting effects on the surrounding normal tissue.
According to QYResearch, Global Medical Linear Accelerators for Radiation market size has reached about 2.28 billion USD in 2016 and the number is forecasted to reach 3.89 billion USD in 2022, with a Compound Annual Growth Rate of 9.35% from 2016 to 2022. In terms of consumption volume, the global Linear Accelerators for Radiation Production was 1488 Sets in 2016, and it is predicted to reach 2431 Sets in 2022, with a Compound Annual Growth Rate of 8.53% from 2016 to 2022.
Based on end users, the downstream market of LINAC is segmented into Hospitals & Clinics, Research Institute & Medical Schools. Hospitals is the major application of Linear Accelerators for Radiation, in 2016, the Linear Accelerators for Radiation consumption (sales) in Hospitals was 1369 Units, and it will reach 2234 Units in 2022; while the sales market share in Hospitals was 92.00% in 2016 and will be 91.90% in 2022.
Major players in this market are Varian Medical Systems, Elekta and ACCURAY. There are also many small players with small output numbers in this market, but the global market pattern will not change very significantly due to the high technical barrier and brand Influential.
This report also covers analysis for major consumption regions like North America and Europe，developing regions like japan and China，and also the potential market like India and South East Asia countries. For more information about this report, visit http://www.qyresearch.com/english/goods.php?id=639303 or contact our analysts directly：